Literature DB >> 9862678

Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.

H T Maecker1, D T Umetsu, R H DeKruyff, S Levy.   

Abstract

This study was designed to test whether cytotoxic T cell (CTL) responses to DNA vaccination are dependent upon MHC class II-restricted priming of CD4+ T cells. Because DNA vaccination may directly transfect dendritic cells, and dendritic cells may be capable of directly stimulating CD8+ T cell responses, such priming might be unnecessary. To test this hypothesis, C57BL/6 mice were immunized intramuscularly or intradermally with DNA encoding either whole OVA, a class I (Kb)-restricted peptide epitope of OVA (amino acids 257-264, SIINFEKL), or this class I-restricted epitope plus the adjacent class II (I-Ab)-restricted epitope of OVA (amino acids 265-280, TEWTSSNVMEERKIKV). Very low to negligible CTL responses were observed in mice vaccinated with the SIINFEKL construct, whereas mice vaccinated with the SIINFEKLTEWTSSNVMEERKIKV or with the complete OVA construct made equally robust CTL responses. These responses were sensitive to blocking by anti-CD8 mAb and were shown to be SIINFEKL-specific by using SIINFEKL peptide-pulsed EL-4 cells as targets. To ensure that the generation of these CTL responses was indeed dependent upon CD4+ T cell help, mice were depleted of either CD4+ or CD8+ cells before immunization. Depletion of CD4+ cells completely abrogated the CTL response to OVA DNA, as did depletion of CD8+ cells. Thus, we conclude that the CTL response to both intramuscular and intradermal DNA vaccination is highly dependent upon the generation of CD4+ T cell help via a class II MHC-dependent pathway. These results will be relevant for the construction of minimal-epitope vaccines for DNA immunization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862678

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Larry D Anderson; Olaf Stüve; Todd N Eagar; Roger N Rosenberg
Journal:  Cell Mol Neurobiol       Date:  2011-04-06       Impact factor: 5.046

2.  The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.

Authors:  Dimitrios Vatakis; Minnie McMillan
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

3.  Insertion of exogenous epitopes in the E3-19K of oncolytic adenoviruses to enhance TAP-independent presentation and immunogenicity.

Authors:  A Rodríguez-García; E Svensson; R Gil-Hoyos; C A Fajardo; L A Rojas; M Arias-Badia; A S I Loskog; R Alemany
Journal:  Gene Ther       Date:  2015-05-21       Impact factor: 5.250

4.  Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.

Authors:  Darrilyn G Fraser; Steve R Leib; Bao Shan Zhang; Robert H Mealey; Wendy C Brown; Travis C McGuire
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

5.  Immunotoxic effect of thiamethoxam in immunized mice with Brucella abortus cultural filtrate antigen.

Authors:  L H Salema; M J Alwan; Afaf Abdulrahman Yousif
Journal:  Vet World       Date:  2016-12-13

6.  Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus.

Authors:  Darrilyn G Fraser; J Lindsay Oaks; Wendy C Brown; Travis C McGuire
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

7.  DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.

Authors:  A E Fujimura; S S Kinoshita; V L Pereira-Chioccola; M M Rodrigues
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues.

Authors:  Olle Bjorkdahl; Karen A Barber; Sara J Brett; Maria G Daly; Christopher Plumpton; Nabil A Elshourbagy; John P Tite; Lindy L Thomsen
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

9.  Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Authors:  Takumi Kumai; Sujin Lee; Hyun-Il Cho; Hussein Sultan; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Cancer Immunol Res       Date:  2016-12-09       Impact factor: 11.151

10.  Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.

Authors:  Toshi Nagata; Yukio Koide
Journal:  J Biomed Biotechnol       Date:  2010-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.